News

AstraZeneca Unit Owes $180 Million-Plus in Syntimmune Case (1)
An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...
Fierce Pharma2d
AstraZeneca takes $181M hit in Syntimmune shareholder lawsuit on top of previous $130M award
For the second time in nine months, a Delaware judge has sided (PDF) with Syntimmune shareholders over AstraZeneca, granting ...
Pharmabiz15h
AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research
AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research: Cambridge, UK Saturday, June 14, 2025, 09:00 Hrs [IST] AstraZeneca has entered a ...
Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...
BioPharma Dive1d
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...
VOV.VN1d
AstraZeneca encouraged to build pharmaceutical manufacturing plant in Vietnam
VOV.VN - Prime Minister Pham Minh Chinh has proposed that AstraZeneca consider building a pharmaceutical manufacturing plant ...
exchange4media1d
AstraZeneca Group appoints Praveen Rao Akkinepally as Managing Director
Sanjeev Kumar Panchal has stepped down as Managing Director of AstraZeneca Group. The company has appointed Praveen Rao ...
AstraZeneca (LSE:AZN) Partners In Quantum Leap For Drug Development Efficiency
AstraZeneca (LSE:AZN) recently entered into a collaborative research initiative with IonQ, AWS, and NVIDIA, focused on ...